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1. Introduction 
Lipids are important dietary components providing unique 
textures and flavors to foods. Yet, dietary fat has been linked 
to obesity (Newgard et al., 2009) and the onset of multiple 
types of diseases, including breast, pancreatic, colorectal can-
cers (Butler et al., 2009; Cho et al., 2003; Nöthlings et al., 2005), 
diabetes (Lindström et al., 2006), and cardiovascular diseases 
(Brousseau & Schaefer, 2000). In particular, coronary heart dis-
ease (CHD) is strongly correlated to dietary fat intake (Jakob-
sen et al., 2009; Kwape et al., 2010). A primary risk for CHD is 
high low-density lipoprotein (LDL) cholesterol (Fernández & 
Webb, 2008). Cholesterol levels among the United States pop-
ulation is disproportionately high (28–32%) exceeding recom-
mended 130 mg/dL levels (Heidenreich et al., 2011). It is ex-
pected that these statistics will be maintained or even increase 
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Abstract 
The lipid fraction of the grain sorghum whole kernel (GS-WK) (i.e., phytosterol rich oil or policosanol rich wax) re-
sponsible for lowering cholesterol in hamsters fed the crude lipid (wax + oil) was determined. As expected, ham-
sters fed an atherogenic diet for a four week period presented with higher plasma non-HDL plasma and liver ester-
ified cholesterol than those on the low fat diet. However, the atherogenic diet containing 5% (w/w) oil significantly 
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liver cholesterol, excreted neutral sterol and bile acid were slightly higher than produced by the atherogenic diet. 
Still, cholesterol excretion negatively correlated with liver cholesterol concentration (r = –0.681, p < 0.001) across 
diets with the oil fraction producing the greatest impact. These combined results indicate that oil plays the most 
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as dietary choices established during early ages are not easily 
altered (Frémeaux et al., 2011). 
Increasing preference for natural interventions for lowering 
LDL, and the potential side effects of cholesterol lowering drugs, 
such as statins, have prompted the discovery several heart health 
food ingredients, including dietary fiber (Erkkilä & Lichtenstein, 
2006), soybean protein (Pipe et al., 2009), tea catechins (Bursill 
& Roach, 2007), and grape polyphenols (Castilla et al., 2006). 
Among these dietary agents, phytosterols have been extensively 
investigated due to their potent LDL lowering properties (Batta, 
Xu, Honda, Miyazaki, & Salen, 2006; Racette et al., 2010). For ex-
ample, meta-analyses of clinical trials have indicated a 10% re-
duction of LDL cholesterol when 2 g of phytosterols are con-
sumed on a daily basis (Carr, Ash, & Brown, 2010). As a result, 
phytosterol-supplemented foods, such as margarine, yogurts, 
and cooking oils, are now commercially available in the US, Eu-
rope, and Australia (Chen, Jiao, & Ma, 2008). Other studies have 
shown a positive link with policosanol consumption and lower 
LDL cholesterol (Castaño et al., 2005; Gamez, Maz, Arruzazabala, 
Mendoza, & Castano, 2005). 
Grain sorghum is critically underutilized in the US despite the 
presence of multiple types of lipids potentially able to prevent 
the onset of diseases currently afflicting western societies (Lee 
et al., 2010). In particular, Carr et al. (2005) showed potent cho-
lesterol lowering properties the crude lipid (oil + wax) fraction 
extracted from grain sorghum whole kernels (GS-WK). Hamsters 
fed a high fat-cholesterol diet supplemented with 1% and 5% 
(w/w) GS-WK lipid presented with substantially lower plasma non 
high density lipoprotein (non-HDL = LDL + very low density li-
poproteins (VLDL)) cholesterol levels and liver esterified choles-
terol compared to the group on a high fat-cholesterol diet alone. 
Other benefits exerted by the 5% (w/w) GS-WK supplement in-
cluded higher HDL levels and increased neutral sterol output. 
Considering the proliferation of evidence supporting the cho-
lesterol lowering benefits of phytosterols (Batta et al., 2006; Ra-
cette et al., 2010), the positive results produced by the GS-WK 
lipids were attributed primarily to the phytoserol rich oil frac-
tion, even though policosanol rich wax accounted for the most 
of the GS-WK lipid crude extract (3:1). 
Therefore, the objective of this study was to determine the 
fraction (wax or oil) in GS-WK responsible for lowering choles-
terol. A hamster model was again fed an atherogenic diet mim-
icking current westernized diets, but supplemented with either 
oil or wax fractionated crude lipid extract at a 5% (w/w) dosage. 
Other groups consumed a diet low in fat or an atherogenic diet 
without GS-WK lipids. Plasma/liver cholesterol profiles and ste-
rol output was monitored for the four groups. In addition, the oil 
and fractions were characterized for their phytosterols and poli-
cosanol content along with other lipid constituents. 
2. Materials and methods 
2.1. GS-WK lipid extraction and fractionation 
Wax and oil fractions were prepared from WK white food-grade 
sorghum, Sorghum bicolor cultivar Macia, grown in Lincoln, 
Nebraska. The kernels (1 kg) were refluxed in their whole form 
with 1 L of hexane for 30 min in a three-neck round bottomed 
flask at approximately 60 °C. After cooling to room tempera-
ture, the extract was filtered through a coffee filter followed by 
a Whatman No.2 filter. The filtrate was maintained at –15 °C for 
12–16 h to precipitate the wax. The waxy precipitate was isolated 
by filtering the cooled extract through a Buchner funnel and 
Whatman No. 42 filter paper, which had been washed with hex-
ane and dried prior to use. The retained wax material was com-
pletely dried, while the hexane was removed from the filtrate 
with a rotary evaporator to obtain the oil fraction. Both fractions 
were stored at –15 °C until sufficient amounts were obtained for 
the animal studies, which occurred approximately three months 
after the first fractions were prepared. 
2.2. Characterization of WK-GS wax and oil 
Wax and oil samples fractionated from the WK were ana-
lyzed for phytosterol and policosanol content by using a gas 
chromatograph (GC) equipped with flame ionization detector 
(FID) as described by Leguizamón, Weller, Schlegel, and Carr 
(2009). Briefly, 1 mL of 5α-cholestane and 0.1 mL of C27 were 
combined with 0.02 g of wax or oil suspended in chloroform. 
The chloroform was evaporated using a heat block (~60 °C) un-
der a nitrogen stream, and the samples were allowed to cool for 
3 min. The samples were saponified with 1 mL of 1 M metha-
nolic KOH and the mixture was heated to 50 °C in a heat block 
for 1 h with occasional agitation. Non-saponifiable lipids were 
extracted by adding 1 mL of deionized water and 2 mL of hex-
ane. The samples were shaken for approximately 2 min and cen-
trifuged prior to transferring the hexane phase to another vial. 
Hexane was evaporated under gaseous nitrogen at a tempera-
ture of approximately 60 °C. The remaining residue was then de-
rivatized with 50 μL of Sylon BTZ (Supelco, Bellefonte, PA, USA) 
for at least 20 min at room temperature. The samples were in-
jected onto a 0.32mm×30m DB-5 capillary column (J&W Scien-
tific, Folsom, CA, USA) at a split ratio of 50:1 with helium serving 
as the carrier gas. The injector and detection temperatures were 
set at 270 and 300 °C, respectively, while the initial oven temper-
ature of 100 °C was ramped to 300 °C at 5 °C/min. Stigmasterol, 
β-sitosterol, and campesterol standards were used to identify/
quantitate the phytosterols, whereas hexacosanol (C26), octaco-
sanol (C28) dotriacontanol (C32) standards were used to charac-
terize the policosanols. Internal standards, 5α-cholestane and 
policosanol C27, were also used for more precise determination. 
Total phytosterols and policosanols were determined by adding 
the contribution of each of the individual detected components. 
Simple lipid profiles were monitored with thin layer chroma-
tography (TLC). Samples of each fraction were suspended in chlo-
roform at a concentration of 20 mg/mL and warmed to 40 °C to 
melt the solid or semi-solid material prior to analysis. Aliquots of 
each (10 μL) were spotted onto a silica 60Å TLC plate (20×20 cm, 
250 μm) and separated with 90:10:2 (v/v/v) hexane, diethyl ether-
acetic acid. To visualize the lipid bands, the plate was submerged 
briefly in a 10% cupric sulfate in 8% phosphoric acid solution, air-
dried in a chemical fume hood and charred at 165 °C for 10 min. 
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Lipid groups were identified against a cocktail of standards con-
taining monoacylglycerols, 1,2-diacylglycerols,1,3-diacylglycer-
ols, triacylglycerols, fatty acid methyl esters, d-α-tocopherol ace-
tate, three polyoxyethlenesorbitan monooleate, and octacosanol. 
Gas chromatography with FID detection was also used to con-
firm the presence of aldehydes and hydrocarbons in each frac-
tion as cited by Verleyen et al. (2001). Briefly, a test sample was 
dissolved in pyridine and combined with N,O-bis(trimethylsilyl) 
trifluoracetamide containing trimethylcholorosilane. Lipid classes 
were resolved in a single run by using a CP-Sil 8 CB (Low bleed/
MS 15m×0.25 mm, 0.1 μm, Varian, Palo Alto, CA, USA) with he-
lium serving as the carrier gas. The initial injection tempera-
ture was set to 60 °C and increased to 140 °C at 30°C/min. The 
oven temperature was ramped from 5 to 235 °C at 5 °C/min, fol-
lowed by a 7 min heating hold, increased to 340 at 15 °C/min, 
followed by a 15 min hold. The detector temperature was main-
tained at 360 °C. 
Lastly, fatty acid profiles were determined with slight modifi-
cations to the method described by Schneider, Cowles, Stuefer-
Powell, and Carr (2000). Boron trifluoride (14%) in methanol was 
added to a sample and heated to 100 °C for 30 min in sealed 
reaction vials. The samples were allowed to cool to room tem-
perature before extracting with 1 mL of hexane and 2 mL water 
washes. The hexane phase was resolved with a GC DB-Wax col-
umn (30m×0.25 mm, J&W Scientific) and detected with FID. In-
jections were achieved with a split ratio of 10:1 with the starting 
temperature set at 185 °C for 12 min. The temperature was in-
creased to 210 °C at 10 °C/min, held for 0–1 min, and increased 
to a final temperature of 230 °C at 10 °C/min, which was main-
tained for the remaining 15 min run time. 
2.3. Animal study and diets 
Four different AIN-93 M purified diets were formulated as 
shown in Table 1. The atherogenic (athero) diet contained coco-
nut oil at the expense of cornstarch compared to the control diet, 
whereas 5% of the GS-WK oil or wax was added to the athero 
diet at the expense of soybean oil and corn starch, respectively. 
Prior to combining the GS-WK lipids to the other dietary ingre-
dients, the wax fraction was finely ground with a commercial 
blender, while the oil fraction was heated to approximately 60 °C. 
Forty-four male Bio-F1B Syrian hamsters (Bio Breeders, Water-
town, MA, USA) were randomly assigned to four groups based 
on diet, each of which were housed individually in polycarbon-
ate cages maintained at approximately 25 °C. The hamsters 
were allowed free access to fresh water and their assigned diet 
throughout the four-week feeding period. The sawdust serving 
as bedding was changed every week, and the fecal material was 
collected during the second and fourth weeks. Body weights and 
food intake were recorded on a weekly basis. At the end of the 
four-week feeding period, the hamsters were fasted for 14 h and 
then euthanized by CO2 asphyxiation. 
2.4. Characterization of plasma/liver samples for 
cholesterols 
Fasting blood samples were collected directly from the heart 
by cardiac puncture using 10-mL syringes containing 10 mg 
of EDTA as an anticoagulant. Red blood cells were removed by 
centrifuging the blood at 1000g for 30 min at 4 °C; 2–4 mL 
plasma was recovered from each hamster. Aprotinin (1 mg/ L) 
and phenylmethylsulphonyl fluoride (80 mg/L) were added to 
the plasma as preservatives. Plasma total cholesterol concentra-
tion was determined enzymatically using our microplate method 
(Carr, Andresen, & Rudel, 1993). Plasma HDL cholesterol concen-
tration was measured after apolipoprotein B precipitation, and 
non-HDL cholesterol (VLDL + LDL) was calculated by difference. 
Previous hamster studies in our laboratory showed that the non-
HDL plasma fraction contains >90% LDL cholesterol (Carr, Cai, 
Lee, & Schneider, 2000). 
Livers were perfused with saline through the portal vein to 
eliminate residual blood before being excised. Gallbladder bile, 
which was collected with a preweighed 31-gauge syringe weight, 
was determined, and the volume was estimated assuming a den-
sity of 1 kg/L. The bile was transferred to a microfuge tube, and 
the syringe was rinsed several times with small volumes of saline. 
Table 1. Composition of diets fed to hamsters. 
Food component (g/kg) Control  Athero  Athero + wax  Athero + oil 
Cornstarch  455.7  354.5  304.5  354.5 
Dextrinized cornstarcha  155.0  155.0  155.0  155.0 
Casein  140.0  140.0  140.0  140.0 
Sucrose  100.0  100.0  100.0  100.0 
Coconut oil  —  100.0  100.0  100.0 
Soybean oil  50.0  50.0  50.0  — 
Insoluble fiber (cellulose)b  40.0  40.0  40.0  40.0 
Soluble fiber (guar gum)  10.0  10.0  10.0  10.0 
Oily fraction  —  —  —  50.0 
Waxy fraction  —  —  50.0  — 
Cholesterol  —  1.2  1.2  1.2 
AIN-93 mineral mix  35.0  35.0  35.0  35.0 
AIN-93 vitamin mix  10.0  10.0  10.0  10.0 
L-cysteine  1.8  1.8  1.8  1.8 
Choline bitartrate  2.5  2.5  2.5  2.5 
a. Dyetrose (Dyets, Bethlehem, PA). 
b. Solka-Floc (International Fiber Corporation, North Tonawanda, NY).   
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Diluted bile was adjusted to a final volume of 0.2 mL. Biliary cho-
lesterol and phospholipid were determined enzymatically (Carr 
et al., 1993), and bile acids were quantified as described previ-
ously for fecal samples. The livers were weighed and immediately 
frozen at –80 °C. Aliquots of frozen liver were minced, and the 
lipids were extracted into chloroform–methanol (2:1, v/v) (Folch, 
Lees, & Sloane-Stanley, 1957). Total cholesterol, free cholesterol, 
and triglyceride were quantified enzymatically (Carr et al., 1993), 
and liver esterified cholesterol was calculated as the difference 
between total and free. 
2.5. Characterization of Fecal Biological Samples 
Nonradioactive feces were collected during week 4 for quan-
tification of cholesterol-derived neutral steroids and bile acids. 
The following neutral steroids were quantified and represent fe-
cal cholesterol and its metabolites: cholesterol, coprostanol, di-
hydrocholesterol, epicoprostanol, epicholestanol, coprostanone, 
and cholestanone. Ground feces (100 mg) were acidified by add-
ing 0.2 mL of 0.5 mol/L HCl. Lipids were then extracted with 
chloroform–methanol (2:1, v/v) (Folch et al., 1957) containing 10 
mg/L 5-cholestane as an internal standard. The lower phase sol-
vent was evaporated, and the samples were saponified in 2 mL 
of 1 mol/L methanolic KOH for 1 h at 50 °C. After the addition 
of 2 mL deionized water, the fecal steroids were extracted into 5 
mL of hexane. The hexane was evaporated under nitrogen, and 
the steroids were derivatized and analyzed by GC as described 
above for GS-WK sterols. 
Fecal bile acid concentration was quantified enzymati-
cally as reported previously (Schneider et al., 2000). Samples 
were measured at 340 nm before and after the addition of 3 
α-hydroxysteroid dehydrogenase to account for background ab-
sorbance. The concentration of total bile acids was calculated by 
the difference of the 2 absorbance readings, compared against a 
cholic acid calibration curve. Excreted plant sterols were quanti-
fied by GC as described in the previous section for determining 
phytosterol content in the GS-WK wax and oil fractions. 
2.6. Statistical analysis 
Lipid characterization data are reported as mean ± stan-
dard deviation (STD) of triplicate analyses, whereas the animal 
data are presented as the mean ± standard error of the mean 
(SEM). After ensuring the animal data were normally distrib-
uted, significance of treatment differences (p < 0.05) were by 
one-way ANOVA using Tukey’s-LSD multiple comparison pro-
cedure (GraphPad InStat, La Jolla, CA, USA). Pearson correlation 
was used to compare fecal cholesterol excretion and liver cho-
lesterol concentrations. 
3. Results and discussion 
3.1. Animal study design and diets 
A Bio-F1B Syrian hamster model was selected for this study 
because their plasma lipoproteins, free/esterified cholesterols, 
and phospholipid profiles in the lipoproteins are similar to those 
in humans (Bravo, Cantafora, Calcabrini, & Ortu, 1994; Kowala, 
Nunnari, Durham, & Nicolosi, 1991). In addition, these ham-
sters are more susceptible to diet-induced atherosclerosis and 
hyperlipidemia (Cheema & Cornish, 2007; Trautwein, Jingsheng, 
& Hayes, 1993). The hamsters were fed an AIN diet containing 
low fat (control), high fat-cholesterol (athero), or high fat-cho-
lesterol supplemented with 5% (w/w) GS-WK wax (athero + wax) 
or 5% (w/w) GS-WK oil (athero + oil) (Table 1) over a four week 
feeding period. Analysis of the body weights (43–50 g) and total 
food intake (194–221 g) at the end of the feeding period were 
not significantly different between the four groups, indicating 
that both GS-WK supplements as high as 5% were palatable and 
did not adversely affect animal growth. 
Both the wax and oil were supplemented at 5% (w/w) of the 
diet based in part to a previous study (Carr et al., 2005) that 
showed an athero diet containing 5% (w/w) of the crude GS-WK 
lipid (wax + oil) resulted in significantly lower non- HDL choles-
terol (69% reduction) and higher plasma HDL cholesterol lev-
els (19% increase) compared to the athero diet alone. The 0.5% 
and 1% GS-WK crude lipid supplemented diet had, respectively 
little or lower (36% reduction) impact on non-HDL cholesterol 
levels. Additionally, liver esterified cholesterol decreased (66%), 
whereas neutral sterol output (47%) and HDL (16%) increased in 
response to the 5% GW-SK crude lipid supplement relative to an 
athero diet. Considering that the GS-WK crude extract contained 
a 3:1 wax to oil ratio, the fractionated GS-WK oil and wax were 
supplemented at higher levels compared to the latter study, par-
ticularly the oil based diet. The 5% level was used for this study 
to provide a phytosterol dose that was within the effective cho-
lesterol lowering dosage of 2 g/d or ~30–40 mg phytosterols/
(kg·d) for a 70 kg adult (Carr et al., 2010). Based on the phytos-
terol present in the GS-WK oil fraction (8.4 ± 1.8 mg/g oil, Table 
2), the amount consumed by the hamsters the last week of the 
feeding period was approximately 2.4–3.7 mg/d, or 48–90 mg 
of phytosterols/(kg·d). 
As expected, phytosterols were not detected in the GS-WK 
wax, while policosanols were not present in the GS-WK oil (Ta-
ble 2). As the GS-WK wax fraction contained 10.8 ± 2.2 mg of 
policosanols/g of wax, with hexacosanol and dotriacontanol 
comprising 84% of this lipid class (Table 2), an estimated 3.1–
4.7 mg policosanols/d of diet were consumed by the hamsters 
fed the GS-WK wax supplemented diet, or 62–115 mg polico-
sanols/(kg·d). The oil contained higher levels unsaturated fats, 
whereas the wax was composed of higher levels saturated lip-
ids (Table 2). Long chained aldehydes were present in the in the 
wax fraction, but were not detected in the oil. Both fractions con-
tained minimal levels of hydrocarbons as confirmed by TLC and 
GC-FID methodologies (data not shown). 
3.2. Plasma cholesterol profiles 
A strong link between plasma LDL cholesterol concentra-
tion and cardiovascular diseases has been well established 
(Fernández & Webb, 2008), whereas hypertriglyceridemia has 
been positively correlated with VLDL levels (Hegele & Pollex, 
2009). Although non-HDL cholesterol is comprised mainly of LDL 
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cholesterol, VLDL cholesterol is present at quantities of <10%. 
Therefore, all four hamster groups were evaluated for plasma 
non-HDL levels (Figure 1). Plasma non- HDL levels were not sig-
nificantly different between the athero + GS-WK wax and the 
athero fed animals, but the athero + GS-WK oil fed animals 
presented with significantly lower non-HDL levels similar to the 
control group. 
Comparison of plasma non-HDL levels in response to WKGS 
fractionated oil and to the GS-WK crude diet (Carr et al., 2005) 
suggest that the latter extract exerted a greater overall benefit 
even though lower amounts of oil were consumed, i.e., ~1.25% 
(w/w) for the 5% (w/w) crude lipid supplement based on 3:1 wax 
to oil ratio (Wang et al., 2005). As stated previously, the athero 
diet supplemented with 1% or 5% (w/w) GS-WK crude lipid re-
sulted in a 36% and 69% reduction in plasma non-HDL levels, 
respectively, when normalized to the athero diet. Alternatively, 
a 25% reduction in non-HDL plasma cholesterol occurred in re-
sponse to the GS-WK oil (Figure 1). This difference could be due 
to slight variations in athero diets used. In the Carr et al. (2005) 
study, the athero diet was prepared with 3% saturated fat and 
0.05% cholesterol. Alternatively, the diets used for this study 
contained 5% saturated fat and 0.12% cholesterol, which may 
have resulted in higher cholesterol levels. If so, there is a possi-
bility that the fractionated GS-WK oil could have exerted non-
HDL responses comparable or even lower than produced by the 
GS-WK crude fraction (Carr et al., 2005). This hypothesis requires 
further testing as the latter study did not use a control diet as a 
point of reference (Table 1). 
However, Hoi et al. (2009) showed that non-HDL levels de-
creased by 27% in hamsters fed an atherogenic diet similar to 
that used for the crude lipid experiment but supplemented 
with 5% (w/w) of grain sorghum dry distiller’s grain with solu-
ble (GS-DDGS). Lower GS-DGGS (0.5% and 1%) dosages did not 
affect non-HDL cholesterol. Moreover, analysis of the GS-DDGS 
showed that the wax fraction only accounted for 3.3% of the 
lipid extract (Hoi et al., 2009). These combined studies suggest 
that the oil and wax present in the GS-WK crude lipid may act 
as synergists or potentiates to elicit a greater benefit than the 
Table 2. Profiles of lipid components of interest in grain sorghum (GS) oil and wax. 
  GS-WK wax  GS-WK oil 
Phytosterols1  Total amount (per mg of lipid)  —  8.4 ± 1.8 
 Sitosterol  —  29.6% 
 Stigmasterol  —  34.9% 
 Campesterol  —  32.3% 
 Stigmastanol  —  3.2% 
Policosanols2  Total amount (mg per g of lipid)  10.8 ± 2.2  — 
 Octacosanol  2.9%  — 
 Triacontanol  8.6%  — 
 Hexacosanol  48.3%  — 
 dotriacontanol  35.7%  — 
 Lignoceryl alcohol  4.4%  — 
Fatty acids3  Myristic acid  —  0.3% 
 Palmitic acid  24.7%  22.1% 
 Palmitoleic acid  —  1.5% 
 Unknown  —  0.3% 
 Stearic acid  12.4%  3.2% 
 Oleic acid  25.0%  31.8% 
 Linoleic acid  27.3%  37.5% 
 Linolenic acid  1.4%  3.4% 
 Eicosanoic acid  9.3%  — 
1. Phytosterols were analyzed by GC coupled with FID as described by Leguizamón et al. (2009). 
2. Policosanols were analyzed by GC after derivatization and silylation as described by Verleyen et al. (2001). 
3. Fatty acids were derivatized to volatile fatty acid methyl esters (FAMEs) and the FAMEs were analyzed by GC coupled with FID as described by 
American Oil Society (2000). Percentage results from the cited compositional analyses are based on relative amounts.   
Figure 1. Plasma lipoprotein cholesterol concentration. 44 male Bio-F1B 
Syrian hamsters separated into 4 groups of 11 were fed one of the fol-
lowing diets during 4 week feeding period: Control diet (Control), ath-
erogenic diet (Athero), atherogenic diet containing 5% grain sorghum 
whole kernel wax (athero + wax), atherogenic diet containing 5% grain 
sorghum whole kernel oil (athero + oil). * Significantly different (p < 0.05) 
compared to control.  
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individual fractions. Such dietary agent interactions have been 
reported for multiple food systems and biological targets (Wag-
ner & Ulrich-Merzenich, 2009). Still, the absolute difference in 
plasma non-HDL cholesterol for the athero + WK-GS crude lipid 
fed group (Carr et al., 2005) and the athero + GS-WK oil fed ani-
mals was 0.6 and 1.05 mmol/L, respectively, relative to the group 
fed only the athero diet in each study. 
HDL cholesterol levels were similar across the athero diets re-
gardless of the supplement but higher compared to the control 
(Figure 1). These results support those reported by Hayes, Liv-
ingston, and Trautwein (1992) who showed that hamsters fed a 
high fat diet presented with higher HDL cholesterol compared to 
the control group. Additionally, Hoi et al. (2009) demonstrated 
that an athero + 5% GS-DGGS supplement, which contained only 
3.3% wax, resulted in HDL levels similar to the athero diet. On the 
other hand, the 5% GS-WK crude lipid supplement produced a 
16% increase in HDL (Carr et al., 2005). Combined, these results 
again suggest that the wax and oil may again be acting syner-
gistically to elevate HDL levels. 
For the study cited herein, the athero diet caused signifi-
cantly higher plasma triacylglycerols (4.98 ± 0.46 mmol/L) rela-
tive to the control diet (3.05 ± 0.22 mmol/L) (data not shown in 
tabulated form). The WK-GS oil was not able to remediate the 
elevated triacylglycerols (4.75 ± 0.30 mmol/L), but the athero + 
WK-GS wax fed animals presented with even higher plasma tria-
cylglycerol levels (6.49 ± 0.41 mmol/L). The effects of the GS-WK 
crude lipid on plasma triacylglycerols were not reported (Carr et 
al., 2005), but the GS-DDGS study showed that triacylglycerols 
were slightly elevated by the predominantly oil based extract at 
doses of 1 and 5% (w/w) (Hoi et al., 2009), which could be due 
to the small amount of policosanols present. 
3.3. Lipid cholesterol profiles 
Free liver cholesterol levels were comparable across the 
athero fed animals with each being slightly higher than the con-
trol (Table 3). Nonetheless, liver triacylglycerol levels were higher 
for only the animals fed the GS-WK oil and wax supplemented 
diets, which may have been due to lower VLDL secretion (Wang, 
Weller, & Hwang, 2005a). At this time we do not have another 
explanation for these results, but similar trends were reported 
for hamsters fed the athero diet supplemented with 5% GS-WK 
crude lipid and 1% and 5% GS-DGGS (Carr et al., 2005; Hoi et 
al., 2009). Liver esterified cholesterol was also significantly higher 
for the athero + GS-WK oil group compared to the control, but 
was considerably lower for the animals fed the athero and the 
athero + GS-WK wax diets (Table 3). 
The unsaturated fatty acids present in the GS-WK oil may be 
partly responsible for the positive overall cholesterol responses 
(Valsta, Jauhiainen, Aro, Katan, & Mutanen, 1992), but the phy-
tosterols are more likely providing the benefits (Figure 1, Table 2). 
Grain sorghum is a rich source of plant sterols compared to other 
commonly consumed cereal grains (Lee et al., 2010). The choles-
terol lowering properties of phytosterols have been reported ex-
tensively for both humans and animal models (Batta et al., 2006; 
Racette et al., 2010). Several studies have linked phytosterols to 
the expression of enzymes involved in cholesterol synthesis, me-
tabolism and transportation (Davis et al., 2004; Field, Born, & 
Mathur, 2004; Plösch et al., 2006). Vanstone, Raeini-Sarjaz, and 
Jones (2001) showed that subcutaneous injections of phytosterols 
suppressed higher levels of circulating cholesterol levels relative 
to orally consumed phytosterols. Other studies have shown that 
changes in gene expression were not directly caused by phytos-
terols but were rather a concomitant result followed by decreased 
cholesterol absorption efficiency (Calpe-Berdiel et al., 2005; Xu, 
Le, & Moghadasian, 2008). The generally accepted mechanism 
is that phytosterols displace dietary cholesterol and recirculat-
ing endogenous cholesterol when mixed micelles that transport 
lipids are formed in the small intestine resulting in reduced cho-
lesterol absorption (Ostlund, 2007). Moreover, Kassis and Jones 
(2006) showed that the consumption of policosanols by human 
subjects did not positively affect plasma total, LDL0, HDL-cho-
lesterol or triglyceride level. These studies used authentic cane 
sugars as an isolated supplement to the individuals normal diets. 
The 5% (w/w) GS-WK crude extract (Carr et al., 2005) as well 
as the 5% GS-DGGS (Hoi et al., 2009) were able to reduce liver 
esterified cholesterol. As stated previously, the animals used for 
both studies were fed the same types of diets in terms of fat con-
tent with only the GS supplement differing. The 5% GS-DDGS 
diet was not able to decrease liver cholesterol (48%) as effec-
tively as the 5% (w/w) crude lipid (66%), whereas the fraction-
ated WK-GS oil resulted in a 64% reduction. We have no expla-
nation for these results except that the minimal amount of wax 
present in the GS-DGGS extract (3.3%) may be adversely affect-
ing hepatic liver lipids. Many components acting as synergists 
or potentiates for a given health benefit can be antagonists for 
other outcomes (Junio et al., 2011). 
3.4. Lipid excretion profiles and correlation with liver 
cholesterol 
Fecal samples were measured for cholesterol output mark-
ers to determine if the fractionated GS-WK oil and/or wax af-
fected cholesterol absorption. Total sterol (neutral + bile salts) 
Table 3. Liver lipid concentrations, μmol/g  
 Control  Athero  Athero + wax  Athero + oil 
Free cholesterol  4.3 ± 0.1a  5.8 ± 0.2b  5.7 ± 0.1b  5.6 ± 0.1b 
Esterified cholesterol  0.6 ± 0.04a  17.4 ± 1.9c  13.1 ± 1.3c  6.2 ± 0.9b 
Triacylglycerol  3.7 ± 0.3a  4.5 ± 0.3a  5.7 ± 0.2b  5.7 ± 0.3b 
Values are means ± SEM, n = 11. Means within a row having different superscripts are statistically different (p < 0.05).  
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output was significantly higher for all the athero fed animals 
compared (Table 4). The excreted sterols were primarily neu-
tral sterols, i.e., cholesterol and its metabolites, such as dihydro-
cholesterol and coprostanol. Cai and Carr (1999) also reported 
that neutral sterols represented the major cholesterol output in 
a hamster model fed a high cholesterol diet. 
Although the GS-WK wax supplement did not lower plasma 
or liver cholesterol, neutral sterol output was 51% higher com-
pared to the athero fed group (Table 4). These results are similar 
to those reported for the GS-WK crude lipid fed animals (47%) 
(Carr et al., 2005) but substantially lower than produced by the 
athero + GS oil diet (125%). As expected, high levels of phy-
tosterols were detected in the fecal material collected from the 
athero + GS-WK oil fed animals (Table 4) as these agents were 
only present in the oil (Table 2). The high phytosterol output in-
dicates that not all of these components were absorbed. 
Interestingly, fecal bile acid output was higher for the athero 
+ GS-WK wax fed group (Table 4). Of the components present 
in the wax fraction, the policosanol class is the most plausible 
agent eliciting this effect (Table 2). Ng, Leung, Huang, and Chen 
(2005) reported a significant increase in excreted bile acids in 
a hamster model fed a policosanol supplemented diet at dos-
ages of 0.75 or 1.5 g/kg of diet, but the 0.35 g supplement had 
no effect. As stated previously, the policosanol content in the 
athero + GS-WK wax diet was 4.3–0.65 g/kg of diet. These lev-
els are higher than present in the 5% GS-WK crude lipid (0.24 g/
kg) (Carr et al., 2005), which had no effect on bile acid excretion. 
Other studies have demonstrated that policosanols may play 
a role in reducing the activity of HMG-CoA, i.e., the rate-limiting 
enzyme in cholesterol synthesis and in increasing LDL receptor 
activity (Crespo et al., 1999; Menéndez et al., 2001). The results 
reported herein do not support these studies, as the athero + 
GS-WK wax diet did not positively impact other metabolic pro-
files (Figure 1 and Table 3), but were consistent with the results 
presented by Wang and Jones (2003), Kassis and Jones (2006); 
Kassis, Marinangeli, Jain, Ebine, and Jones (2007). It must be 
noted that this fraction contained higher amounts of saturated 
fatty acids (Table 2), which have been linked to elevated LDL lev-
els (Siri-Tarino, Sun, Hu, & Krauss, 2010). Long chain aldehydes 
were also present in the GS-WK wax, but studies have not been 
completed on their participation in cholesterol absorption to 
our knowledge. 
Sterols levels (in the form of bile acids, cholesterol, or its me-
tabolites) have been correlated with and liver and plasma cho-
lesterol levels (Charach, Rabinovich, Argov, Weintraub, & Rabi-
novich, 2012; Meissner et al., 2011). For example, Carr et al. 
(2005) showed a positive correlation between plasma non-HDL 
cholesterol levels and cholesterol absorption in response to 
higher GS-WK crude lipid consumption (r = 0.07, p = 0.034), sug-
gesting that dietary GS-WK crude lipid lowers non-HDL choles-
terol, at least in part, by inhibiting dietary cholesterol absorption. 
On the other hand, GS-DGGS diet produced a strong negative 
correlation between fecal cholesterol excretion and liver choles-
terol concentration in a dose dependent manner (r = –0.97, p = 
0.026), indicating a dependency of intestinal cholesterol uptake 
on liver cholesterol levels. 
For these studies, a negative correlation (r = –0.687, p < 
0.001) (Figure 2) existed between cholesterol output (in the form 
of neutral sterols) with total liver cholesterol concentration that 
trended with diet. The GS-WK oil and athero based diets pro-
duced the greatest and lowest impact, respectively, with the wax 
diet falling in between. The results indicate that GS-WK oil plays 
the major role in reducing liver cholesterol levels by inhibiting di-
etary cholesterol absorption, but the policosanols containing wax 
may also provide such benefits, albeit not as potent. A review 
by Jones, Dassis, and Marinangeli (2009) has reported on the 
controversy of the cholesterol lowering ability of policosanols, 
concluding that there is no strong data to suggest that polico-
sanols are effective cholesterol lowering compounds. Indeed, 
we agree with this assertion as isolated compounds; however, 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Correlation between cholesterol output and total liver choles-
terol concentration. 44 male Bio-F1B Syrian hamsters separated into 4 
groups of 11 were fed one of the following diets during 4 week feeding 
period: Control diet (Control), atherogenic diet (Athero), atherogenic diet 
containing 5% grain sorghum whole kernel wax (athero + wax), athero-
genic diet containing 5% grain sorghum whole kernel oil (athero + oil). 
Table 4. Fecal sterol excretion 
 Control  Athero  Athero + wax  Athero + oil
                                                                 μmol day–1 100 g–1 body weight
Bile acids  1.05 ± 0.13a  1.42 ± 0.13b  2.01 ± 0.12c  1.67 ± 0.08b
Neutral sterols  1.76 ± 0.11a  4.55 ± 0.25b  6.85 ± 0.47c  10.24 ± 0.53d
Phytosterols  0.64 ± 0.08a  0.42 ± 0.07a  0.61 ± 0.19a  3.72 ± 0.21b
Values are means ± SEM, n = 11. Means within a row having different superscripts are statistically different (p < 0.05).
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we do also recommend that policosanols could act as a syner-
gist or potentiates in complex systems in light of the health ben-
efits data generated from WK and GS-DDGS story. 
4. Conclusion 
Comparison of two fractionated GS-WK lipid (wax and oil) 
shows that the oil is primarily responsible for lowering both 
plasma and liver cholesterol levels. A possible mechanism for 
this benefit is dietary cholesterol absorption inhibition. None-
theless, consumption of GS wax resulted in elevated sterol ex-
cretion in the form of bile acids and neutral sterols. Although 
this fraction did not directly impact plasma and liver cholesterol, 
lipid profiles were not adversely impacted. These results in com-
bination with other reported studies (Carr et al., 2005; Hoi et al., 
2009) suggest that the wax may act as a synergist or potentiate 
by eliciting a greater effect than the sum of the individual parts. 
More studies are needed to test this hypothesis. This study does 
show that the oil is the most post cholesterol lowering fraction 
and thus has a great potential as a heart health functional food 
ingredient. Such an application would provide other opportuni-
ties for grain sorghum development for western markets.   
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